Exodus Point Capital Management, LP Edgewise Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $9.1 Billion
- Q3 2025
A detailed history of Exodus Point Capital Management, LP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 14,672 shares of EWTX stock, worth $333,788. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,672
Previous 45,255
67.58%
Holding current value
$333,788
Previous $593,000
60.03%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding EWTX
# of Institutions
186Shares Held
112MCall Options Held
188KPut Options Held
121K-
Orbimed Advisors LLC San Diego, CA15.5MShares$353 Million8.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.4MShares$237 Million2.9% of portfolio
-
Baker Bros. Advisors LP New York, NY7.31MShares$166 Million0.97% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.17MShares$140 Million3.22% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$137 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.44B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...